Symbol
GLMD on Nasdaq
Investment type
Equity / Ordinary Shares, NIS 1.80 par value per share
Latest Disclosed Ownership
44.1K shares
Security Ownership
2.6%

Allen Baharaff ownership in Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD)

2025-02-18 - Allen Baharaff has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 44.1K shares of Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD). This represents 2.6% percent ownership of the company.